Clinical development of Orthoclone OKT3.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D016031:Liver Transplantation; D016853:Muromonab-CD3; D011897:Random Allocation; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D016853:Muromonab-CD3